Literature DB >> 15606799

Porin of Shigella dysenteriae enhances Toll-like receptors 2 and 6 of mouse peritoneal B-2 cells and induces the expression of immunoglobulin M, immunoglobulin G2a and immunoglobulin A.

Avijit Ray1, Tapas Biswas.   

Abstract

Porin of Shigella dysenteriae type 1 increased the mRNA levels for Toll-like receptors TLR2 and TLR6, by 1.8-fold and twofold, respectively, in peritoneal cavity B-2 cells from C57BL/6 mice, implicating that the co-expression of TLR2 and TLR6 occurs as a combinatorial repertoire in response to porin. Among the two key TLRs, TLR2 and TLR4, which are primarily responsible for recognizing the majority of bacterial products, TLR2 alone participates in porin recognition. TLR2 expression was increased on B-2 cells, whereas the expression of TLR4 remained unaffected. Besides TLRs, mRNA for myeloid differentiation factor 88 (MyD88), an effector molecule associated with the TLR-mediated response, was enhanced by twofold, suggesting its involvement in the activity of porin. The B-2 cells showed a 1.8-fold increase in mRNA expression of the signalling molecule, nuclear factor-kappa B (NF-kappaB), in the presence of porin. Porin treatment of B-2 cells selectively up-regulated the expression of the costimulatory molecule, CD86, by 4.4-fold. Porin induced the cell-surface expression of immunoglobulin (Ig)M, of IgG2a preferentially among the IgG subclasses, and of IgA, on B-2 cells. The porin-mediated inductions of IgG2a and IgA were augmented by interleukin-6 on B-2 cells, by 2.7- and 1.6-fold, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15606799      PMCID: PMC1782058          DOI: 10.1111/j.1365-2567.2004.02002.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Differential development of progenitor activity for three B-cell lineages.

Authors:  A B Kantor; A M Stall; S Adams; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.

Authors:  G J Freeman; F Borriello; R J Hodes; H Reiser; K S Hathcock; G Laszlo; A J McKnight; J Kim; L Du; D B Lombard
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

Review 3.  Origin of murine B cell lineages.

Authors:  A B Kantor; L A Herzenberg
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 4.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 5.  Interleukin-6 in biology and medicine.

Authors:  S Akira; T Taga; T Kishimoto
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

6.  The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin.

Authors:  F G Mackinnon; Y Ho; M S Blake; F Michon; A Chandraker; M H Sayegh; L M Wetzler
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

7.  GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3.

Authors:  P O Livingston; M J Calves; F Helling; W D Zollinger; M S Blake; G H Lowell
Journal:  Vaccine       Date:  1993-09       Impact factor: 3.641

8.  Purification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1.

Authors:  S Roy; A B Das; A N Ghosh; T Biswas
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice.

Authors:  E Gärdby; P Lane; N Y Lycke
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

10.  Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate.

Authors:  L M Wetzler; Y Ho; H Reiser; L W Wetzler
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  11 in total

1.  Hemolysin induces Toll-like receptor (TLR)-independent apoptosis and multiple TLR-associated parallel activation of macrophages.

Authors:  Deep Chandan Chakraborty; Gayatri Mukherjee; Pallavi Banerjee; Kalyan K Banerjee; Tapas Biswas
Journal:  J Biol Chem       Date:  2011-08-16       Impact factor: 5.157

Review 2.  Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity.

Authors:  Lee M Wetzler
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

3.  The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activity.

Authors:  Deana N Toussi; Xiuping Liu; Paola Massari
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

4.  Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response.

Authors:  Ismael Secundino; Constantino López-Macías; Luisa Cervantes-Barragán; Cristina Gil-Cruz; Nora Ríos-Sarabia; Rodolfo Pastelin-Palacios; Miguel Angel Villasis-Keever; Ingeborg Becker; José Luis Puente; Edmundo Calva; Armando Isibasi
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

5.  Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Authors:  Heather MacLeod; Navneet Bhasin; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

6.  The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein.

Authors:  Ricardo Silvestre; Ana M Silva; Anabela Cordeiro-da-Silva; Ali Ouaissi
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

7.  Listeria monocytogenes-derived listeriolysin O has pathogen-associated molecular pattern-like properties independent of its hemolytic ability.

Authors:  Anu Wallecha; Laurence Wood; Zhen-Kun Pan; Paulo C Maciag; Vafa Shahabi; Yvonne Paterson
Journal:  Clin Vaccine Immunol       Date:  2012-11-07

Review 8.  Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.

Authors:  Sudeep Kumar; Raju Sunagar; Edmund Gosselin
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

9.  Do Engineered Nanomaterials Affect Immune Responses by Interacting With Gut Microbiota?

Authors:  Mingxing Tang; Shuo Li; Lan Wei; Zhaohua Hou; Jing Qu; Liang Li
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

10.  Genomic Region Containing Toll-Like Receptor Genes Has a Major Impact on Total IgM Antibodies Including KLH-Binding IgM Natural Antibodies in Chickens.

Authors:  Tom V L Berghof; Marleen H P W Visker; Joop A J Arts; Henk K Parmentier; Jan J van der Poel; Addie L J Vereijken; Henk Bovenhuis
Journal:  Front Immunol       Date:  2018-01-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.